Herlig nyhet og bekrefter Asieris sin gjennomfĂžringsevne.
âThe combined use
of Hexvix (APL-1706) and BLC for the management of non-muscle invasive bladder
cancer (NMIBC) has been included in the global expert consensus guidelines and
Chinese Urological Association Guideline.â
Merker ogsĂ„ at Hexvix/BLC allerede, fĂžr godkjenning, er tatt inn som anbefalt behandling hos âChinese Urological Association Guidelineâ